Yimeng Gao
gaoym@tongji.edu.cn
English, Chinese
Shanghai
Tongji University
Life Sciences
  • 2011 - Bachelor's Degree: Ocean University of China
  • 2017 - PhD: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
  • 2022 - Selected for Shanghai's 'Overseas High-Level Talent Introduction Plan'
  • 2017-2022 - Yale University School of Medicine, Postdoctoral Research
  • 2022-present - Tongji University, Distinguished Research Fellow under the 'Young Hundred Talents Plan'
  • 2023-present - Tongji University Affiliated Oriental Hospital, Distinguished Research Fellow
  • 2014: Cell Press China Paper of the Year
  • 2017: Top Ten Medical Advances in China
  • 2018: First Prize, Shanghai Science and Technology Award (Ranked 4th)
  • 2019: James Hudson Brown - Alexander B. Coxe Fellowship at Yale University School of Medicine
  • 2021: ASH Scholar Award from the American Society of Hematology
Regulation of hematopoietic development
Inflammatory response effects on blood regeneration and cellular aging
Energy metabolism in the development of blood diseases
Mechanisms of small molecule inhibitors in cancer immunotherapy
  • ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m(6)A modification-mediated RNA stability control, Gao Y*, Zimmer JT, Vasic R, Liu C, Gbyli R, Zheng SJ, Patel A, Liu W, Qi Z, Li Y, Nelakanti R, Song Y, Biancon G, Xiao AZ, Slavoff S, Kibbey RG, Flavell RA, Simon MD, Tebaldi T, Li HB, Halene S*, 2023
  • In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2, Gbyli R, Song Y, Liu W, Gao Y, Biancon G, Chandhok NS, Wang X, Fu X, Patel A, Sundaram R, Tebaldi T, Mamillapalli P, Zeidan AM, Flavell RA, Prebet T, Bindra RS, Halene S*, 2022
  • Transcriptome-wide quantification of double-stranded RNAs in live mouse tissues by dsRIP-Seq, Gao Y, Chen S, Halene S, Tebaldi T*, 2021
  • m(6)A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development, Gao Y, Vasic R, Song Y, Teng R, Liu C, Gbyli R, Biancon G, Nelakanti R, Lobben K, Kudo E, Liu W, Ardasheva A, Fu X, Wang X, Joshi P, Lee V, Dura B, Viero G, Iwasaki A, Fan R, Xiao A, Flavell RA, Li HB, Tebaldi T, Halene S*, 2020
  • The role of RNA epigenetic modification in normal and malignant hematopoiesis, Vasic R, Gao Y, Liu C, Halene S*, 2020
  • Distinct Gene Expression and Epigenetic Signatures in Hepatocyte-like Cells Produced by Different Strategies from the Same Donor, Gao Y, Zhang X, Zhang L, Cen J, Ni X, Liao X, Yang C, Li Y, Chen X, Zhang Z, Shu Y, Cheng X, Hay DC, Lai D, Pan G, Wei G, Hui L*, 2017
  • Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes, Shi XL, Gao Y, Yan Y, Ma H, Sun L, Huang P, Ni X, Zhang L, Zhao X, Ren H, Hu D, Zhou Y, Tian F, Ji Y, Cheng X, Pan G, Ding YT, Hui L*, 2016
  • Direct reprogramming of human fibroblasts to functional and expandable hepatocytes, Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, Cen J, Chen X, Liu C, Hu Y, Lai D, Hu Z, Chen L, Zhang Y, Cheng X, Ma X, Pan G, Wang X, Hui L*, 2014
  • 生物人工肝研究进展, 高义萌, 孙露露, 惠利健, 2016
  • 细胞命运转变——癌化和转分化的研究, 高义萌, 惠利健, 2014
Hematopoietic Stem Cells Leukemia Myelodysplastic Syndromes Gene Mutations Rna Modifications M6A Energy Metabolism Glycolysis Oxidative Phosphorylation Cancer Immunotherapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.